{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:40:38Z","timestamp":1794037238445,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00192-021-04991-9","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T16:10:28Z","timestamp":1633882228000},"page":"3035-3043","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Psychometric evaluation of the Overactive Bladder Questionnaire (OAB-q) for measuring quality of life and clinical implications in Greek patients with overactive bladder"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8832-1209","authenticated-orcid":false,"given":"Stavros","family":"Kontogiannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Athanasopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Tsagkarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kontodimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"4991_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/RRU.S102441","volume":"8","author":"RS Eapen","year":"2016","unstructured":"Eapen RS, Radomski SB. Review of the epidemiology of overactive bladder. Res Rep Urol. 2016;8:71\u20136. https:\/\/doi.org\/10.2147\/RRU.S102441.","journal-title":"Res Rep Urol"},{"issue":"1","key":"4991_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/nau.23277","volume":"37","author":"IGR Melotti","year":"2018","unstructured":"Melotti IGR, Juliato CRT, Tanaka M, Riccetto CLZ. Severe depression and anxiety in women with overactive bladder. Neurourol Urodyn. 2018;37(1):223\u20138. https:\/\/doi.org\/10.1002\/nau.23277.","journal-title":"Neurourol Urodyn"},{"key":"4991_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2490-13-11","volume":"13","author":"JC Avery","year":"2013","unstructured":"Avery JC, Stocks NP, Duggan P, Braunack-Mayer AJ, Taylor AW, Goldney RD, et al. Identifying the quality of life effects of urinary incontinence with depression in an Australian population. BMC Urol. 2013;13:11. https:\/\/doi.org\/10.1186\/1471-2490-13-11.","journal-title":"BMC Urol"},{"key":"4991_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.archger.2017.11.005","volume":"75","author":"EO Caplan","year":"2018","unstructured":"Caplan EO, Abbass IM, Suehs BT, Ng DB, Gooch K, Kirby C, et al. Impact of coexisting overactive bladder in Medicare patients with osteoporosis. Arch Gerontol Geriatr. 2018;75:44\u201350.","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"4991_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/01443615.2017.1349082","volume":"38","author":"A Karabulut","year":"2018","unstructured":"Karabulut A, Simavl\u0131 S, Demirta\u015f \u00d6, \u00d6k N, G\u00fcng\u00f6r HR, Z\u00fcmr\u00fctba\u015f A. Evaluation of overactive bladder and nocturia as a risk factor for hip fracture in climacteric women: a matched pair case control study. J Obstet Gynaecol. 2018;38(2):252\u20136. https:\/\/doi.org\/10.1080\/01443615.2017.1349082.","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"4991_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/nau.22377","volume":"33","author":"V Khullar","year":"2014","unstructured":"Khullar V, Espuna-Pons M, Marschall-Kehrel D, Fianu-Jonasson A, Kelleher CJ, Brubaker L, et al. Clinical value of a patient-reported goal-attainment measure: the global development of self-assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms. Neurourol Urodyn. 2014;33(1):90\u20134.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"4991_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s11934-004-0079-6","volume":"5","author":"LS Matza","year":"2004","unstructured":"Matza LS, Zyczynski TM, Bavendam T. A review of quality-of-life questionnaires for urinary incontinence and overactive bladder: which ones to use and why? Curr Urol Rep. 2004;5(5):336\u201342.","journal-title":"Curr Urol Rep"},{"issue":"6","key":"4991_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1023\/a:1016370925601","volume":"11","author":"K Coyne","year":"2002","unstructured":"Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11(6):563\u201374. https:\/\/doi.org\/10.1023\/a:1016370925601.","journal-title":"Qual Life Res"},{"issue":"3","key":"4991_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.urology.2005.09.035","volume":"67","author":"C Acquadro","year":"2006","unstructured":"Acquadro C, Kopp Z, Coyne KS, Corcos J, Tubaro A, Choo M-S, et al. Translating overactive bladder questionnaires in 14 languages. Urology. 2006;67(3):536\u201340.","journal-title":"Urology."},{"issue":"7","key":"4991_CR10","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1524-4733.2008.00346.x","volume":"11","author":"KS Coyne","year":"2008","unstructured":"Coyne KS, Margolis MK, Thompson C, Kopp Z. Psychometric equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2008;11(7):1096\u2013101.","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"2","key":"4991_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5213\/inj.2012.16.2.77","volume":"16","author":"S-J Oh","year":"2012","unstructured":"Oh S-J, Son H, Kim SW, Lee K-S, Choo M-S, Kim S-O, et al. Psychometric properties of the Korean version of the overactive bladder questionnaire (OAB-q) in a Korean population. Int Neurourol J. 2012;16(2):77\u201385. https:\/\/doi.org\/10.5213\/inj.2012.16.2.77.","journal-title":"Int Neurourol J"},{"issue":"12","key":"4991_CR12","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1111\/j.1742-1241.2010.02489.x","volume":"64","author":"S McKown","year":"2010","unstructured":"McKown S, Abraham L, Coyne K, Gawlicki M, Piault E, Vats V. Linguistic validation of the N-QOL (ICIQ), OAB-q (ICIQ), PPBC, OAB-S and ICIQ-MLUTS questionnaires in 16 languages. Int J Clin Pract. 2010;64(12):1643\u201352.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"4991_CR13","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s11136-004-6014-y","volume":"14","author":"E Pappa","year":"2005","unstructured":"Pappa E, Kontodimopoulos N, Niakas D. Validating and norming of the Greek SF-36 health survey. Qual Life Res. 2005;14(5):1433\u20138.","journal-title":"Qual Life Res"},{"issue":"1","key":"4991_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.urology.2012.04.004","volume":"80","author":"I Milsom","year":"2012","unstructured":"Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80(1):90\u20136.","journal-title":"Urology."},{"issue":"1","key":"4991_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An international Urogynecological association (IUGA)\/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4\u201320.","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"4991_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/s0895-4356(98)00081-x","volume":"51","author":"JE Ware Jr","year":"1998","unstructured":"Ware JE Jr, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol. 1998;51(11):903\u201312. https:\/\/doi.org\/10.1016\/s0895-4356(98)00081-x.","journal-title":"J Clin Epidemiol"},{"key":"4991_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","volume":"2","author":"M Tavakol","year":"2011","unstructured":"Tavakol M, Dennick R. Making sense of Cronbach\u2019s alpha. Int J Med Educ. 2011;2:53\u20135. https:\/\/doi.org\/10.5116\/ijme.4dfb.8dfd.","journal-title":"Int J Med Educ"},{"issue":"8","key":"4991_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/BF03261903","volume":"32","author":"S Arlandis","year":"2012","unstructured":"Arlandis S, Ruiz MA, Errando C, Villacampa F, Arum\u00ed D, Lizarraga I, et al. Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish overactive bladder questionnaire-short form. Clin Drug Investig. 2012;32(8):523\u201332.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"4991_CR19","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/nau.24074","volume":"38","author":"IM Groenendijk","year":"2019","unstructured":"Groenendijk IM, Scheepe JR, Noordhoff TC, Blok BFM. The validation of the Dutch OAB-q SF: an overactive bladder symptom bother and health-related quality of life short-form questionnaire. Neurourol Urodyn. 2019;38(6):1775\u201382.","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"4991_CR20","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/nau.24093","volume":"38","author":"AM Suskind","year":"2019","unstructured":"Suskind AM, Kowalik C, Quanstrom K, Boscardin J, Zhao S, Reynolds WS, et al. The impact of frailty on treatment for overactive bladder in older adults. Neurourol Urodyn. 2019;38(7):1915\u201323.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"4991_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12325-019-0880-8","volume":"36","author":"KM Johnston","year":"2019","unstructured":"Johnston KM, Walker DR, Lakzadeh P. Characterizing the health-related quality of life burden of overactive bladder using disease-specific patient-reported outcome measures: a systematic literature review. Adv Ther. 2019;36(3):548\u201362.","journal-title":"Adv Ther"},{"key":"4991_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12955-015-0274-9","volume":"13","author":"KS Lee","year":"2015","unstructured":"Lee KS, Choo MS, Seo JT, Oh SJ, Kim HG, Ng K, et al. Impact of overactive bladder on quality of life and resource use: results from Korean burden of incontinence study (KOBIS). Health Qual Life Outcomes. 2015;13:89.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"4991_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40520-020-01712-y","volume":"33","author":"D Pizzol","year":"2021","unstructured":"Pizzol D, Demurtas J, Celotto S, Maggi S, Smith L, Angiolelli G, et al. Urinary incontinence and quality of life: a systematic review and meta-analysis. Aging Clin Exp Res. 2021;33(1):25\u201335.","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"4991_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2011.05.065","volume":"61","author":"V Kupelian","year":"2012","unstructured":"Kupelian V, Wei JT, O\u2019Leary MP, Norgaard JP, Rosen RC, McKinlay JB. Nocturia and quality of life: results from the Boston area community health survey. Eur Urol. 2012;61(1):78\u201384.","journal-title":"Eur Urol"},{"issue":"5","key":"4991_CR25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4321\/S0004-06142010000500007","volume":"63","author":"M Espu\u00f1a-Pons","year":"2010","unstructured":"Espu\u00f1a-Pons M, Blasco P, P\u00e9rez M, Rebollo P. Nocturia in patients with overactive bladder. Arch Esp Urol. 2010;63(5):363\u201372.","journal-title":"Arch Esp Urol"},{"key":"4991_CR26","doi-asserted-by":"crossref","unstructured":"Michel MC, Schumacher H, Mehlburger L, de la Rosette JJMCH. Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study Front Pharmacol 2020;11:816.","DOI":"10.3389\/fphar.2020.00816"},{"issue":"3","key":"4991_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5213\/inj.2011.15.3.135","volume":"15","author":"SJ Jeong","year":"2011","unstructured":"Jeong SJ, Homma Y, Oh S-J. Korean version of the overactive bladder symptom score questionnaire: translation and linguistic validation. Int Neurourol J. 2011;15(3):135\u201342.","journal-title":"Int Neurourol J."},{"issue":"3","key":"4991_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0302-2838(02)00014-3","volume":"41","author":"M Goepel","year":"2002","unstructured":"Goepel M, Hoffmann JA, Piro M, R\u00fcbben H, Michel MC. Prevalence and physician awareness of symptoms of urinary bladder dysfunction. Eur Urol. 2002;41(3):234\u20139.","journal-title":"Eur Urol"},{"issue":"8","key":"4991_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/nau.20705","volume":"28","author":"KS Coyne","year":"2009","unstructured":"Coyne KS, Matza LS, Brewster-Jordan J. \u201cWe have to stop again?!\u201d: the impact of overactive bladder on family members. Neurourol Urodyn. 2009;28(8):969\u201375.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"4991_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta10060","volume":"10","author":"JL Martin","year":"2006","unstructured":"Martin JL, Williams KS, Abrams KR, Turner DA, Sutton AJ, Chapple C, et al. Systematic review and evaluation of methods of assessing urinary incontinence. Health Technol Assess. 2006;10(6):1\u2013132 iii\u2013iv.","journal-title":"Health Technol Assess"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-021-04991-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-021-04991-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-021-04991-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T13:02:42Z","timestamp":1665838962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-021-04991-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4991"],"URL":"https:\/\/doi.org\/10.1007\/s00192-021-04991-9","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Stavros Kontogiannis declares that he has no conflict of interest. Anastasios Athanasopoulos has received research grants from Astellas, Pfizer, Lilly and Alergan and speaker honoraria from Astellas, Pfizer, Lilly, Alergan, Meditrina, Galenika and Ranbaxy. Michail Tsagkarakis declares that he has no conflict of interest. Nikolaos Kontodimopoulos declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclaimers\/Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}